RAPS: FDA Adds 34 New and 33 Revised Bioequivalence Study Recommendations for Generic Drug Developers
25.10.2016
The US Food and Drug Administration (FDA) on Tuesday published 67 generic drug-specific recommendations (34 new and 33 revised) describing the agency’s expectations for developing generics that are therapeutically equivalent to reference-listed drugs (RLDs).
SciencePharma
